Chemoinformaics analysis of 3,4-DIHYDROXY-3,4-DIHYDRO-2H-PYRAN-2,6-DICARBOXYLIC ACID
| Molecular Weight | 204.134 | nRot | 2 |
| Heavy Atom Molecular Weight | 196.07 | nRig | 8 |
| Exact Molecular Weight | 204.027 | nRing | 1 |
| Solubility: LogS | -3.628 | nHRing | 1 |
| Solubility: LogP | 2.895 | No. of Aliphatic Rings | 1 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 22.6383 |
| nHD | 4 | BPOL | 11.4977 |
| QED | 0.624 |
| Synth | 4.362 |
| Natural Product Likeliness | 2.334 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.256 |
| MDCK | 0.0000232 |
| BBB | 0.984 |
| PPB | 0.494634 |
| VDSS | 1.037 |
| FU | 0.40909 |
| CYP1A2-inh | 0.13 |
| CYP1A2-sub | 0.124 |
| CYP2c19-inh | 0.057 |
| CYP2c19-sub | 0.441 |
| CYP2c9-inh | 0.088 |
| CYP2c9-sub | 0.747 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.393 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.208 |
| CL | 11.459 |
| T12 | 0.282 |
| hERG | 0.003 |
| Ames | 0.005 |
| ROA | 0.018 |
| SkinSen | 0.074 |
| Carcinogencity | 0.27 |
| EI | 0.932 |
| Respiratory | 0.789 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.930296 |